Minerva Neurosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Minerva Neurosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2024.
  • Minerva Neurosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $22.5M.
  • Minerva Neurosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.31M, a 88% increase year-over-year.
  • Minerva Neurosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$30M, a 6.55% increase from 2022.
  • Minerva Neurosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$32.1M, a 35.7% increase from 2021.
  • Minerva Neurosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$49.9M, a 2671% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.31M $22.5M +$30.3M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$33.6M -$8.23M -$2.04M -33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-05
Q1 2024 -$31.6M -$8.57M -$1.6M -22.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-05
Q4 2023 -$30M -$9.02M -$2.3M -34.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$27.7M -$7.82M -$920K -13.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 -$26.8M -$6.19M +$2.53M +29% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-05
Q1 2023 -$29.3M -$6.97M +$2.79M +28.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-05
Q4 2022 -$32.1M -$6.73M +$14.6M +68.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$46.7M -$6.9M +$2.3M +25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$49M -$8.72M +$1.87M +17.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$50.9M -$9.76M -$960K -10.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$49.9M -$21.3M -$14M -191% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 -$35.9M -$9.21M -$1.09M -13.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$34.8M -$10.6M -$40.1M -136% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 $5.29M -$8.8M +$3.35M +27.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 $1.94M -$7.32M +$22.6M +75.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-08
Q3 2020 -$20.7M -$8.11M +$5.85M +41.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$26.5M $29.5M +$42M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$68.5M -$12.2M +$3.68M +23.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$72.2M -$29.9M -$16.7M -127% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$55.5M -$14M -$1.94M -16.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-08
Q2 2019 -$53.5M -$12.5M +$53K +0.42% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-08
Q1 2019 -$53.6M -$15.8M -$3.41M -27.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-08
Q4 2018 -$50.2M -$13.2M -$13.4M -8250% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-09
Q3 2018 -$36.8M -$12M -$761K -6.76% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-09
Q2 2018 -$36M -$12.5M -$2.75M -28.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-09
Q1 2018 -$33.3M -$12.4M -$1.77M -16.7% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-09
Q4 2017 -$31.5M $162K +$9.57M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$41.1M -$11.3M -$2.84M -33.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-12
Q2 2017 -$38.3M -$9.78M -$4.57M -87.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-12
Q1 2017 -$33.7M -$10.6M -$2.64M -33% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-12
Q4 2016 -$31M -$9.4M -$965K -11.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$30.1M -$8.42M -$2.48M -41.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$27.6M -$5.21M +$1.4M +21.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$29M -$8M -$1.91M -31.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$27.1M -$8.44M -$997K -13.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$26.1M -$5.94M +$21.2M +78.1% Jul 1, 2015 Sep 30, 2015 10-K 2018-03-12
Q2 2015 -$47.3M -$6.61M +$12.8M +65.9% Apr 1, 2015 Jun 30, 2015 10-K 2018-03-12
Q1 2015 -$60.1M -$6.09M -$3.16M -107% Jan 1, 2015 Mar 31, 2015 10-K 2018-03-12
Q4 2014 -$56.9M -$7.44M -$5.32M -250% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 -$51.6M -$27.2M -$26.7M -5465% Jul 1, 2014 Sep 30, 2014 10-K 2017-03-13
Q2 2014 -$24.9M -$19.4M -$19M -5051% Apr 1, 2014 Jun 30, 2014 10-K 2017-03-13
Q1 2014 -$5.93M -$2.94M -$2.67M -984% Jan 1, 2014 Mar 31, 2014 10-K 2017-03-13
Q4 2013 -$3.26M -$2.13M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-26
Q3 2013 -$488K Jul 1, 2013 Sep 30, 2013 10-K 2015-03-26
Q2 2013 -$376K Apr 1, 2013 Jun 30, 2013 10-K 2015-03-26
Q1 2013 -$271K Jan 1, 2013 Mar 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.